Product

Donepezil Dihydroxynaphthalate

1 clinical trial

1 indication

Indication

Alzheimer's disease

Clinical trial

A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects

Status: Not yet recruiting, Estimated PCD: 2025-03-31